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1. Introduction 
Human trichomoniasis caused by protozoan parasite, Trichomonas vaginalis is one of the 
most prevalent non-viral sexually transmitted urogenital disease with more than 180 million 
cases annually worldwide. Annual incidence varies between 0-65 percent depending upon 
different geographical locations, age groups and population studied. In North America and 
Canada, more than 8 million new cases are reported annually, with an estimated rate of 
asymptomatic cases as high as 50 percent (Sobel, 2005). The number may be underestimated 
as symptomatic patients may be underdiagnosed because of insensitive wet mount 
procedure and most of the infected subjects remain asymptomatic, thus are not being 
reported (Petrin et al, 1998). Recent review on Global epidemiology in high risk populations 
and control of T.vaginalis has  highlighed that the burden of infection is found in resource-
limited settings and high risk groups in industrialized settings. The World Health 
Organization estimated global prevalence figures are based on a wet mount microscopy 
(sensitivity range of 60-80%), however recent data, using PCR suggests sensitivity may be 
lower (35-60%), thus underestimating global prevalence (Johnston and Mabey, 2008) In 
India, hospital based studies reveal 4-10 percent positivity in symptomatic women attending 
gynaecology clinics and almost similar percentage in asymptomatic women attending 
infertility, post-natal and family planning clinics (Sharma et al, 1988; Malla et al, 1989; 
Divekar et al, 2000; Vishwanath et al, 2000;Valadkhani et al, 2003; Chakraborty et al, 2005; 
Yadav et al, 2006). The significantly higher percentage has been observed amongst 
contraceptive users (7.31%), antenatal patients (7.59%) and women with gynaecological 
disorders (9.21%) compared to postnatal (3.62%) and infertile woman (2.83%) (Sharma et al, 
1988). The association of infection with contraceptive practices indicates controversial 
figures. Lazer (1970) found an increase, McLellan et al (1982) found no such correlation 
while Krieger et al (1985) found prevalence to be less amongst women using oral 
contraceptive and Sharma et al (1988) found barrier contraceptive to be protective. This 
observation and the tendency for symptomatic disease to occur during menstrual periods, 
suggests a hormonal component to the susceptibility. In contrast, Demes et al (1988) 
reported fewer parasites in vaginas of infected women during menstruation, suggesting 
trichomonacidal effect of menstrual blood complement in-vivo and survival of parasites 
during menstrual bleeding has been explained by the existence of subpopulations of 
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trichomonads that are resistant to complement lysis. The infection is low in women in 
higher socio-economic groups and high (55%) in the developing countries and in minority 
groups of industrialized populations (Tapsall et al, 1979). Based on family income, we have 
observed that 90% infected women belonged to middle and lower socio economic status, 
while only 10% were from upper socio-economic status, thereby indicating that socio-
economic factors seem to play role in this infection (Kaur et al, 2008). 
The infected men are usually asymptomatic, acting as carriers of infection. In men with non-
gonococcal urethritis (NGU), although a median prevalence of 11 percent is suggested 
(Krieger, 1990), yet it varies from 10% to 21% in adolescents at high risk and 45% in those 
who have been in contact with infected women (Sobel, 2005). Report from India revealed 
that one (2.5%) out of 40 NGU male patients harboured T.vaginalis (Dawn et al, 1995). The 
rate of transmission from men to women appears to be higher (67-100%) than the other way 
round (14-80%) suggesting that in men, the disease is self limiting (Rein and Muller, 1990) 
and parasites are spontaneously cleared, possibly by the trichomonacidal action of prostatic 
secretions (Langley et al, 1987) or due to mechanical elimination of protozoa during 
micturition (Rein, 1990).  
T.vaginalis and HIV infections are both sexually transmitted, yet there are controversial 
reports of the association of presence of T.vaginalis and HIV. No significant differences were 
observed between the presence of parasite and status of HIV infection from studies 
conducted in different geographical locations (Minkoff et al, 1999; Frankel and Monif, 2000; 
Susan et al, 2002; Klinger et al, 2006). It is concluded that HIV infection does not make a 
woman more likely to have prevalent, incident, persistent or recurrent trichomoniasis 
(Susan et al, 2002). No association of prevalence of T.vaginalis in HIV infected women and 
CD4+ cell count has been found (Sorvillo et al 1998). In support of this, in our study, none of 
the 100 HIV seropositive patients including 30% patients with <200/µl CD4+ cell count was 
found to harbour T.vaginalis (Kaur et al, 2008). The reason for absence of T.vaginalis in the 
study may be because most of the females (71%) were sexually inactive and 25% were using 
different contraceptive devices. In contrast, two cross-sectional studies in Africa (Ter Muelen 
et al, 1992; Ghys et al, 1995) and in Mexico (Bersoff-Matcha et al, 1998) have demonstrated 
an association between T.vaginalis and HIV infection in women. T.vaginalis was found in 
18.6% HIV positive and 10.2% HIV negative pregnant women (Sutton et. al, 1999). 
T.vaginalis infected HIV women had 4.2 fold reduction in the quantity of cell-free HIV-I 
virus in vaginal secretions following metronidazole therapy (Wang et al, 2001). Study from 
Tanzania showed that treatment of trichomoniasis in HIV-infected women decreased 
vaginal HIV RNA levels. It is concluded that control of T.vaginalis infection may be single, 
most cost effective strategy for reducing the incidence of HIV transmission (Gosskurth et 
al,1995). It is postulated that although T.vaginalis infection may not be significantly high in 
HIV infected women, yet the Trichomonas infected subjects may be more susceptible and at 
higher risk of acquiring the HIV infection.  
Although, sexual mode of transmission is the only documented route of acquisition of 
infection, yet, 2-17 percent female offspring of mothers infected with T.vaginalis acquired 
urinary tract trichomoniasis or vaginal infection (Rein and Muller, 1990) and 2 infants 
suffering from respiratory tract infection were delivered vaginally by infected mothers 
indicating respiratory route of infection (McLaren et al, 1983). The parasites have been 
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reported from toilet seat towels and allied objects, but, so far, no case of fomite transmission 
has been documented (Heine and McGregor, 1993). 
2. The parasite 
Honigber and King (1964) have detailed out initially the morphological characteristics of 
this urogenital pathogen and further detailed morphological, parasitological, biochemical 
and clinical aspects of the parasite have been amply reviewed earlier (Petrin et al, 1998; 
Schwebke and Burgess, 2004). Recently with the cracking of the genome of the parasite, and 
identification of 26,000 confirmed genes, the new ways of diagnosing and treating the 
disease may come to light (Carlton et al, 2007). It is postulated that an additional 34,000 
unconfirmed genes are on the way for identification. 
3. Pathogenesis 
The exact mechanism of pathogenesis is still under elucidation. Reports have revealed 
multifaceted interplay of parasite and host factors leading to different clinical spectrum. 
Initial events invariably have been focused on parasite factors revealing cell-to cell adhesion, 
haemolytic activity, pore-forming proteins, excretion of extracellular proteinases and cell 
detaching factors playing significant role in pathogenesis (Fiori et al, 1999). Host factors 
include role of Lactobacilii, local pH, hormonal components, humoral and cytokine 
responses and free radical generation (oxidative stress and No radicals). 
3.1 Adherence and adhesions 
Cytoadherence, one of the early steps in the infection process is essential for colonization. 
Initially, following cytoadherence, parasite changes its morphology from pear shape to 
amoeboid form with numerous cytoplasmic projections interdigetating with the microvilli 
of the host cell plasma membrane (Arroya et al, 1993) and allowing the formation of isolated 
intracelllular spaces (Gonzalez et al, 1995). The adherence is specifically mediated by four 
adhesion proteins (AP 65, 51, 33 and 23) which act in a specific receptor-ligand interaction 
and is time, temperature and pH dependent. The adhesions are concentrated on the side 
opposite the undulating membrane while laminin binding proteins are ubiquitous on the 
entire surface of the parasite (Costa et al, 1988). Parasite binds to numerous host 
macromolecules which may serve a nutritive purpose while few may protect the parasite by 
modifying their host defences, thereby helping in evasion of the host immunity (Honigberg, 
1990). In Vitro studies have indicated time dependent significant difference in the 
percentage of vaginal epithelial cells (VEC) attached by trichomonads as well as number of 
parasites attached per VEC in T.vaginalis isolates from symptomatic and asymptomatic 
women. Significant difference in attachment of VEC’s was observed only during first 15 
minutes while maximum number of VEC’s attached by parasite was significantly different 
at initial 20 to 25 minutes following incubation of VEC’s and parasites (Valadkhani et al 
2003). These observations suggest that adhesion proteins and / or other virulence markers 
may be playing significant role in the initial stages of attachment. Experimental studies 
revealed that sustained infection in mice could only be induced in presence of Lactobacillus 
acidophilus (McGrory and Garber, 1992). L.acidophilus may be playing role in sustaining 
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trichomoniasis by providing low pH (4-4.5) in the environment. In vitro study demonstrated 
that in presence of L.acidophilus more number of VEC’s were found attached by T.vaginalis as 
compared to controls and significant reduction was observed in presence of excretory 
secretory products of L.acidophilus (Valadkhani et al, 2003), thereby suggesting that adhesion 
of parasite to target cells is pH dependent. 
T.vaginalis alpha-actinin is diffusely present throughout the parasite before interaction with 
target cell and gets localized in the peripheral regions of the amoeboid cell which is 
accompanied by an enhanced expression of the genes coding for some cytoskeletal 
components (Fiori et al, 1999). T.vaginalis cysteine proteinase 30 (CP30) has been found to 
bind to host cell surface and shown to play a role in cytoadherence (Menduza-Lopez et al, 
2000). CP30 was detected in 40 fresh T.vaginalis isolates from both symptomatic and 
asymptomatic women, while intensity of CP30 band was significantly higher in isolates 
from symptomatic as compared to asymptomatic women. In long term culture maintained 
isolates, the band was detected in all the 20 (100%) isolates from symptomatic women and 
only in 14 (70%) isolates from asymptomatic women, thereby suggesting that CP30 
expression of isolates leading to symptomatic infection appears to be more stable 
characteristic (Yadav et al, 2007). Further, CP30 was detected in serum and vaginal washes 
of 100% T.vaginalis infected women and in 65% serum and 80% vaginal wash samples from 
15 asymptomatic infected women. Antibody to CP30 was detected in 100% serum samples 
of both symptomatic and asymptomatic women, in 54.5% vaginal washes of symptomatic 
and 35% asymptomatic women and also in 3/20 (15%) serum samples from uninfected 
women, thereby suggesting that besides CP30, other factors may also be playing role in 
leading to symptomatic infection (Yadav et al, 2007a).  
3.2 Haemolysis 
T.vaginalis is capable of producing haemolysis and utilizing haemoglobin as a source of iron. 
Experimental studies have indicated that virulence of parasite is reduced under iron 
depleted conditions (Ryu et al, 2001). The parasite possibly causes lysis of red blood cells 
both by contact dependent (Krieger et al, 1985; Fiori et al, 1999; Valadkhani et al, 2003) and 
contact independent mechanisms (Pindak et al, 1993). The contact of parasite with RBC’s is 
thought to derive lipids and iron. This is suggested mechanism to exacerbate the symptoms 
during and following menstruation. The temperature and Ca2+ dependent mechanisms of 
haemolysis suggest the role of pore-forming proteins, which are able to insert themselves in 
the lipid bilayer of the target cell, forming transmembrane channels that lead to cell death, 
by osmotic lysis. The size of the pores formed on the target cell membrane is between 1.14 
and 1.34 nm and alteration of membrane permeability eventually leads to cell lysis and loss 
of haemoglobin. The pore-forming proteins are active at pH lower than 6.5 and at 37oC. 
Electron microscopic studies have revealed that following parasite and target cell 
interaction, the change in shape of the target cell is due to loss of spectrin, the predominant 
protein of the RBC cytoskeleton and acid intact, metabolically active parasites can disrupt 
the target cell spectrin which is contact dependent (Fiori et al, 1999). The parasite has a 
haemolytic Phospholipase A (pore forming proteins) which is rich in membranes, 
hydrogenosomes, vesicles and vacuoles. The three pathogenic isolates showed maximum 
hemolytic activity at pH 6.0 and 8.0, indicating that the parasite have both acidic and 
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alkaline hemolysins and activity was also related to type of RBC’s from different sources, rat 
and human (Vargas – Villarreal et al, 2003).  
3.3 Free radical generation 
It is apparent that free radicals play a critical role in a variety of normal regulatory pathways 
and oxidant-antioxidant balance is important for immune cell function. Trichomonads are 
equipped with several oxygen scavenging systems localized in both cytoplasm and 
hydrogenosomes. The main systems operating in the cytoplasm consists of NADH and 
NADPH oxidases, (Linstead & Bradley, 1988) which reduce O2 to H2O and H2O2 
respectively. Polymorphs recruited at the site of infection and when activated, initiate 
oxidative stress by releasing toxic oxidants such as superoxide anion and H2O2, which lead 
to cell damage surrounding VEC’s. Shaio et al (1991) observed that neutrophil could kill 
T.vaginalis only in presence of normal human serum, indicating that trichomonicidal activity 
is complement dependent. However, low concentration of C ◌ٰ in vagina may explain 
survival of the parasite in presence of significant number of PMN’s. Davis and Lushbaugh ( 
1993) observed inter-strain heterogenity in the oxidative stress response of T.vaginalis. The 
parasite has developed mechanisms to deal with oxidative stress and upon exposure to 
H2O2, it upregulates the production of various heat shock proteins (Bozner,1997). 
Experimental study showed that vaginal tissue (VT) of mice infected with isolates from 
symptomatic women generated significantly higher superoxide radicals (SOD) while 
vaginal washes (VW) and blood samples generated less SOD as compared to mice infected 
with isolates from asymptomatic women(Valadkhani et al, 2006). It is suggested that 
different responses by VT, VW and blood may be due to functional differences in different 
tissue and circulating PMN’s.  
Nitric oxide appears to play an important function as a cytotoxic effector molecule for 
several parasites. Significant increase in reactive nitrogen intermediates (RNI) levels in mice 
infected with T.vaginalis isolates from infected women as compared to uninfected controls 
has been reported (Malla et al, 2004). The inducible nitric oxide synthase (iNOS) protein and 
RNI was detected in leucocytes (stimulated with T.vaginalis in vitro) and VW of all the 
T.vaginalis infected 22 symptomatic and 20 asymptomatic women studied. The mean iNOS 
protein band intensity was significantly higher in leucocytes of asymptomatic as compared 
to symptomatic women, while no significant difference was observed in VW between 
symptomatic and asymptomatic women. The study suggested that reactive nitrogen radicals 
may be playing role in limiting T.vaginalis infection (Yadav et al, 2006).  
3.4 Other mechanisms 
Host humoral immune responses to the parasite seem to be important determinants of 
virulence. High concentrations of IgG, IgM and IgA antibody to trichomonads have been 
observed in serum from experimental infected animals and infected subjects. Specific IgG 
and IgA are present in vaginal washes from women with trichomoniasis and significantly 
higher IgA levels have been found in vaginal secretions in asymptomatic than symptomatic 
women suggesting its role in preventing the establishment of infection (Ackers et al, 1975; 
Sharma et al, 1991). Significant increase in specific IgG and particularly IgG1 was observed 
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in experimental study (Yadav et al, 2005) and in infected human subjects (Kaur et al 2008). It 
is suggested that the IgG and IgM may be playing significant role in establishing 
symptomatic infection. T.vaginalis can coat itself with host plasma proteins, thus hosts 
immune system does not recognize the parasite as foreign (Peterson and Alderete, 1982) and 
continuous release of antigens may neutralize antibody or cytotoxic T lymphocytes, thus 
short-circulating specific anti-T.vaginalis defense mechanisms (Alderete and Garza, 1984). 
Numerous CP’s secreted by the parasite degrade IgG, IgM and IgA, allowing the parasite to 
survive the antibody response (Provenzano and Alderete, 1995). It is proposed that the 
balance between different IgG subclasses influences the clinical outcome of infection in 
various parasitic diseases. 
Cytokines and chemokines provide a mechanism for initiation, amplification or containment 
of inflammation during disease status. Experimental studies have revealed that the Th-I 
cytokine (IL2 and IFN-γ) responses might play a role in the elimination of T.vaginalis 
(Paintlia et al, 2002; Malla et al, 2007) and thus might be maintaining low levels of infection 
in asymptomatic infected subjects.  
It is observed that the parasite induces cell death in host cells via apoptosis. The study 
indicated that p38 MAPK signaling cascade is requisite to apoptosis of T.vaginalis infected 
macrophage, and apoptotic process occurs via the phosphorylation of p38 MAPK, which is 
located downstream of mitochondria-dependent caspase activation, conferring insight into 
the plausible molecular mechanism of T.vaginalis- immune evasion from macrophage attack 
(Chang et al, 2006).  
Recently, the influence of T.vaginalis lysate and excretory-secretory  products (ESP) on the 
fate of neutrophils has been reported.  The study revealed that T.vaginalis lysate inhibits 
apoptosis of human neutrophils. It is  suggested that an intrinsic mitochondrial pathway of 
apoptosis was involved in T.vaginalis lysate-induced delayed neutrophil apoptosis and this 
phenomenon may  contribute to local inflammation in trichomoniasis (Song et al, 2010).  
3.5 Molecular mechanisms 
Molecular analysis of the membrane molecules and virulence factors have begun. The recent 
sequencing of the T.vaginalis genome has allowed comprehensive computational analysis of 
the general transcription machinery and the identification of novel eukaryotic DNA 
involved in directing gene expression in this parasite. Identification of Genes, particularly, 
required for synthesis of an unusual nucleotide sugar found in T.vaginalis 
lipophosphoglycan, the monosaccharide rhamnose, which is absent in the human host, may 
make it a potential drug target. Genes involved in sialic acid biosynthesis consistent with the 
reported presence of this sugar on the parasite surface were identified. It is suggested that 
the discovery of previously unknown metabolic pathways, the elucidation of pathogenic 
mechanisms, and the identification of candidate surface proteins likely involved in 
facilitating invasion of human mucosal surfaces may provide potential leads for the 
development of new therapies and novel methods for diagnosis (Carlton et al, 2007).  
Control of gene expression is essential to the survival of an organism and with the 
available genome data, additional analyses have been made possible.  The wealth of data 
present in the T.vaginalis genome has been utilized to identify aspects of an array of 
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biological processes, including small nuclear RNAs involved in splicing of introns, 
components of transcriptional complexes and the presence of discrete DNA elements that 
direct basal transcription. It is suggested that both evolutionarily conserved and novel 
features of T.vaginalis serve to inspire further questions specifically concerning this 
parasite, as well as the molecular mechanisms shared with other eukaryotic groups (Smith 
and Johnson, 2011). 
4. Clinical spectrum 
The clinical spectrum in women ranges from asymptomatic carrier state in approximately 50 
percent infected women while symptomatic patients may complain of vaginal discharge in 
50-75 percent, with pruritus in 25-50 percent and dysuria in 30-50 pertcent and dyspareunia 
in 10-50 percent (Heine and McGregor, 1993;  Valadkhani et al, 2003; Kaul et al, 2004). 
Infection during pregnancy may be associated with premature rupture of membranes, 
preterm delivery, low birth weight babies and also respiratory infection in infants. The 
disease may be associated with endometritis and cervical erosion with predisposition to 
malignant transformation. There are contrasting reports of association of cervical carcinoma 
and presence of T.vaginalis. Kharsany et al (1993) in the study conducted in Durban have 
found no association while reports from other areas (Boyle et al, 1989; Zhang & Begg, 1994; 
Zhang et al, 1995; Vikki et al, 2000) indicated significant association. T.vaginalis could not be 
isolated in any of the 100 cervical cancer patients in our earlier study (Kaur et al, 2008).  
In infected females, perspeculum examination usually reveals copious loose discharge that 
pools in the posterior vaginal formix and bubbles may be seen in about 10 to 33 percent. The 
vaginal epithelium is inflamed in 15 percent with small punctate haemnorrhagic spots on 
vaginal and cervical mucosa in 2 percent (Rein, 1990).  
In men, the clinical spectrum varies from asymptomatic carrier state to acute state 
characterized by profuse purulent urethritis and mild symptomatic infection including 
scanty clear to mucopurulent discharge, dysuria and mild pruritus or burning sensation 
immediately after sexual intercourse (Krieger, 1990; Schwebke and Burgess, 2004). 
5. Laboratory diagnosis 
Laboratory diagnosis is established by examination of wet mount preparation of vaginal 
discharge and / or urine specimen. This method is least cost-effective but has low sensitivity 
(38% - 82%) (Petrin et al, 1998). Best results are obtained, if wet smear preparation is 
examined in bed side laboratory, within half an hour, as parasites thereafter loose motility. 
Low sensitivity is attributed to the loss of motility after the parasite has been removed from 
body temperature. The broth culture method is the gold standard, has been found most 
sensitive for routine diagnosis and requires 300 to 500 trichomonads/ml of inoculum 
(Sharma et al, 1991a; Petrin et al, 1998). “In PouchTM culture has been found with added 
advantages and can be conveniently transported from the site of collection to the laboratory 
(Sood and Kapil,2008).The main  limitation for its routine use is the high cost involved. Cell 
culture technique is reported superior to broth culture, since it is able to detect T.vaginalis at 
a concentration as low as 3 parasites/ml (Garber et al, 1987). However, it is not routinely 
performed because it is expensive and not convenient for rapid diagnosis (Petrin et al, 1998). 
Although, antigen in vaginal secretions and specific circulating and local antibody 
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response have been demonstrated in infected subjects (Ackers et al, 1975; Alderete, 1984; 
Sharma et al, 1991), yet it has limited value in diagnosis due to lower sensitivity than 
culture technique. Anti-trichomonad, IgA antibodies decreased significantly post 
treatment and appear to be specific to the presence of parasite in the urogenital tract 
(Sharma et al, 1991). Review of reports indicates that DNA detection in clinical samples by 
PCR yielded higher sensitivity than wet mount and culture (Schwebke and Burgess, 2004). 
It requires expertise and availability. Further research is required to develop cheap, point 
of care diagnostic tests which will allow a greater understanding of T.vaginalis 
epidemiology (Johnston and Mabey, 2008). 
6. Strain variation 
The reasons for different clinical spectrum ranging from asymptomatic to acute and chronic 
symptomatic state and complications are still unclear, although, data supports that in 
addition to host factors, differences in parasite intrinsic virulence play role in such 
phenomenon. The differences in virulence in different strains by In-Vivo (Honigberg et al, 
1966) and In-Vitro (Honigberg, 1990) assays have been reported. The In-Vivo virulence 
assays in experimental mouse model have shown that intraperitoneal infection of 
trichomonads produces visceral (pancreatic and hepatic) necrosis and extent of necrosis is 
proportional to the level of virulence of the inoculated strain, which can result in death. The 
effect of two strains, one highly virulent and other very mild strain on chick embryo 
fibroblast cultures was quite different. The pathogenic changes caused by the virulent 
parasites appeared much sooner and were far more extensive than those observed with 
mild-strain. A correlation between the length of time In Vitro of T.vaginalis strains and the 
attenuation of their virulence for cell cultures was observed. Although, the extrapolation of 
data from In Vitro experiments and In-Vivo animal models to human situation needs to be 
interpreted with caution, few recent molecular studies support these earlier observations. 
Antigenic heterogenicity (Krieger et al, 1985a) has differentiated T.vaginalis isolates and has 
been correlated with pathogenicity (Mason and Gwanzura, 1988). Isoenzyme analysis 
(Soliman et al, 1982;Vohra et al, 1991) and restriction digestion patterns (Sapru et al, 1994) 
could not differentiate clinical isolates from symptomatic and asymptomatic women. 
Phenotypic (Alderete et al, 1986, 1987) and genotypic variation by RAPD analysis 
(Vanacova et al, 1997) have demonstrated the presence of different strains, We have 
reported that dendogram based on RAPD data obtained from fresh 30 (15 each from 
symptomatic and asymptomatic women) T.vaginalis isolates showed upper branch 
representing 7 out of 15 isolates, from symptomatic women and other eight isolates 
constituted another cluster, whereas all the isolates from 15 asymptomatic women were 
represented in lower branch of the tree. The study indicated that the RAPD traits can be of 
utmost importance in differentiating isolates from symptomatic and asymptomatic 
women (Kaul et al, 2004).  
Further, the same 30 isolates were maintained in culture for long term (6 months to 2 yrs) 
and were subjected to RAPD analysis. Following long term cultivation changes in RAPD 
patterns were observed. The phylogenetic tree of same 30 long term (up to 2 years) culture 
maintained isolates divided the isolates into two distinct branches. The upper half of tree 
represented all 15 isolates from symptomatic women, while the lower half of the tree 
represented all 15 isolates from asymptomatic women (Fig. 1.) (Kaul 2004a). 
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Fig. 1. Dendrogram constructed by RAPDistance programme for 30 long term culture 
isolates of T.vaginalis. The integers represent branch lengths, which reflect the genetic 
distance between the isolates. 
7. Trichomonas Vaginalis Virus (TVV) 
Double stranded RNA virus has been identified in T.vaginalis (Wang and Wang, 1985) and 
was found in about 50% clinical isolates. It was thought that most probably this virus is 
transferred from parent to progeny. Presence of TVV correlated with 270 kDa surface 
protein (P270) positive isolates and on long term culture loss of TVV was associated with 
absence of P270 (Wang et al, 1987). The loss of viral dsRNA and concomitant absence of the 
surface disposition of specific immunogens strengthens the likelihood of involvement of 
virus in the sequestration of immunogens into trichomonal membranes. All virus 
harbouring trichomonads contained at least three dsRNA segments (5.5, 4.8 to 4.3 kb) and 
the study suggested segmented nature of the TVV (Khoshnan and Alderete, 1993). Different 
studies from different geographical locations indicated different sizes of the segments of 
TVV (Tai et al, 1993; Shaio et al, 1993). It is suggested that T.vaginalis may be reservoir for 
several different dsRNA viruses simultaneously (Benchmol et al, 2002). Older women 
patients, infected with T.vaginalis were found with virus positive isolates as compared to 
younger patients and men. We analysed presence of dsRNA virus in T.vaginalis same 30 
Indian isolates (15 each from symptomatic and asymptomatic women) in whom RAPD 
analysis was carried earlier (Kaul et al, 2004) and presence of three bands (5.5, 2.5 and 1.5 
kb) were observed in all the 30 fresh isolates, while following long term cultivation (up to 2 
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years) TVV was observed only in 7 isolates, (3 from symptomatic and 4 asymptomatic 
women isolates) (Malla et al, 2011). The study suggests that genetic changes might be taking 
place during in vitro cultivation of parasites and this might be related to phenotypic 
variation and loss of dsRNA virus. No significant association was found between isolates 
from symptomatic and asymptomatic women and presence of TVV (P >0.05), which is in 
agreement with an earlier report (Wendel et. al, 2002). The same fresh isolates were also 
subjected to in vitro metronidazole drug resistance assay. The study suggests that the 
presence of TVV alone may not be a virulence marker and loss of TVV on long term 
cultivation of T.vaginalis isolates appear to be related to drug resistance. Correlation of 
absence of TVV and drug resistance (p<0.05) in our study supports the earlier studies (Wang 
and Wang, 1985; Snipes et al, 2000). However, on retrospective analysis of presence of TVV 
and drug sensitivity with RAPD analysis of isolates, no significant correlation was found, 
which is in agreement to the earlier report (Stiles et al, 2000), whereby no significant 
correlation between metronidazole resistance and RFLP subtypes was reported. In contrast, 
Vanacova et al. ( 1997) have reported that all the 5 isolates refractory to metronidazole 
constituted single branch of tree by RAPD analysis. Out of these 5 isolates, 4 were 
metronidazole resistant while fifth was susceptible to metronidazole by in vitro assay. 
Metronidazole resistance existing in a closely related group of isolates indicated that only 
one or few mutations have occurred which resulted in resistance. It is suggested that some 
genealogical line of T.vaginalis may be genetically predisposed for the development of 
metronidazole resistance and same may be true for the capability of strains to cause disease 
in patients. The contrasting correlations in different reports from different geographical 
locations may be due to phenotypic and genotypic variations.  
8. Treatment and drug resistance 
Nitromidazole derivatives are drugs of choice for the treatment of trichomoniasis. The 
standard treatment is metronidazole 250 mg thrice a day given orally for 7 days or in a 
single 2 gm dose. The infected patient and sexual partner, both should be  
treated irrespective of symptomatology, to prevent reinfection. The drug does  
cross placental barrier, therefore is not prescribed during first trimester of pregnancy 
(Lossick and Kent, 1991).  
Drug resistant cases have been reported (Sobel, 1999). It can be due to several mutational 
changes and can affect both aerobic and anaerobic mechanisms of metabolism (Upcroft 
and Upcroft, 2001). In the parasites resistant by aerobic mechanisms, the transcription of 
ferridoxin (Fd) gene is reduced, thereby decreasing the ability of cell to activate the drug. 
However, gene knock out mice were not found resistant to the drug under aerobic or 
anaerobic conditions and it is postulated that Fd gene product eliminated in knock out 
cells is neither necessary for hydrogen production nor metronidazole production (Land et 
al, 2004). Metronidazole has to be first reduced by certain mechanism(s) in T.vaginalis at 
the relatively low redox potential, before it exerts the antitrichomonad action (Muller et 
al, 1983). It is suggested that reductase(s) responsible for reducing metronidazole or its 
precursor, could be transitional product of dsRNA in T.vaginalis. The studies suggest that 
it might be possible to identify a marker for resistance that could lead to improved 
treatment strategies. 
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Many alternative drugs and treatments have been tested in vivo in cases of refractory 
trichomoniasis, as well as in vitro with some successes including the broad spectrum anti-
parasitic drug nitazoxanide. Drug resistance incidence of T.vaginalis appears to be on the 
increase and improved surveillance of treatment failures is urged ( Dunne et al, 2003). 
9. Prevention and control 
The main focus to prevent and control the disease should be on the identification of 
infected women and treatment of both the sexual partners. High rates of asymptomatic 
infection in male partners of infected females and subsequent re-infection have significant 
implications for control programmes. HIV-infected women are at increased risk of 
trichomoniasis and local HIV prevention strategies should target such women for 
intervention efforts. In addition, the effect of treatment on outcome of pregnancy and HIV 
acquisition requires further study. This will, in turn, facilitate operational studies 
evaluating optimal control strategies and their impact on the complications of T.vaginalis 
(Johnston and Mabey, 2008). 
Vaccine 
The Solco Trichovac Vaccine prepared from inactive Lactobacilli was thought to induce 
protection, however, further reports indicated its inconclusive efficacy. Experimental studies 
revealed that the mice which were  inoculated whole, live trichomonads with adjuvant/s 
subcutaneously and then infected intravaginally, had significantly less intravaginal infection 
than control groups ( Abraham et al, 1996). High levels of proteolytic activity found in 
T.vaginalis and involvement of some of these proteases in the colonization of the host 
suggest that proteases may have protective role. Intranasal immunization of T.vaginalis 62 
kDa protease in a murine model induced significant IgG and IgA response against this 
antigen in the vaginal washes and suggests that the 62kDa protease is a potential vaccine 
candidate against trichomoniasis (Hernandez et al, 2006). The reports provides hope for the 
goal of vaccine development in future. 
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Sexually transmitted infections (STIs) are infections that are spread primarily through person to person sexual
contact. There are more than 30 different sexually transmissible bacteria, viruses and parasites. STIs lead to
high morbidity and complications. This book entitled as Sexually Transmitted Infections is not a text book but
provides useful information for general reference work for physicians, researchers and students interested in
the subject. Each chapter is abundant in tips useful to general readers as well. It also includes the Introductory
chapter providing an overview with special emphasis on syndromic approach to the management of STIs in
clinical setting.
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